HEIDELBERG, Germany--Lion Bioscience has signed a licensing agreement allowing Boehringer Ingelheim Pharma to use Lion's bioinformatics platform, bioScout, to analyze sequence data and predict functions of target genes. As part of the agreement, Lion established a secure data line between its supercomputing facility here and Beohringer's research laboratories in Ingelheim, giving scientists there 24-hour confidential, exclusive access to data.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.